Reader response: Symptom burden among individuals with Parkinson disease: A national survey
Citation Manager Formats
Make Comment
See Comments

We read with great interest the study by Tarolli et al.,1 which explored the burden of disease in Parkinson disease (PD) by evaluating the prevalence of nonmotor symptoms and their association with quality of life. The authors selected nonmotor symptoms based on literature review, expert opinions, and patient interviews. We note that apathy, which has major consequences for patients and carers, was not included as a relevant nonmotor symptom in their study. We performed a subcohort analysis of 60 patients from a study of pain in PD in 110 outpatients (PaCoMo-study, registered trial number: NL6311402917 [toetsingonline.nl]). We retrospectively reviewed the medical records to check whether the clinician identified apathy in these patients in the previous year, which was the case in 15% of the patients (n = 9). Blind to those results, patients were examined with the Apathy Scale (AS).2 In total, 63.3% (n = 38) of the patients scored positive on the AS. Only 18.4% of the patients who scored positive on the AS were also classified or mentioned with apathy in the medical records by clinicians.
Apathy, an important nonmotor symptom of PD, is often missed or minimized by clinicians. When apathy is acknowledged, treatment can lead to better outcomes for patients.3
Footnotes
Author disclosures are available upon request (ncpjournal{at}neurology.org)
- © 2020 American Academy of Neurology
References
- 1.↵
- Tarolli CG,
- Zimmerman GA,
- Auinger P, et al
- 2.↵
- 3.↵
- Devos D,
- Moreau C,
- Maltête D, et al
The Nerve!: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
Dr. Robert Pitceathly and Dr. William Macken
► Watch
Related Articles
Alert Me
Recommended articles
-
Research
Symptom burden among individuals with Parkinson diseaseA national surveyChristopher G. Tarolli, Grace A. Zimmerman, Peggy Auinger et al.Neurology: Clinical Practice, November 18, 2019 -
Article
Reduced cognitive function in patients with Parkinson disease and obstructive sleep apneaVictoria P. Mery, Priti Gros, Anne-Louise Lafontaine et al.Neurology, February 22, 2017 -
Article
Withdrawing amantadine in dyskinetic patients with Parkinson diseaseThe AMANDYSK trialFabienne Ory-Magne, Jean-Christophe Corvol, Jean-Philippe Azulay et al.Neurology, December 26, 2013 -
Article
Co-occurrence of apathy and impulse control disorders in Parkinson diseaseBonnie M. Scott, Robert S. Eisinger, Matthew R. Burns et al.Neurology, October 01, 2020